Prolonged treatment of human pancreatic cancer cell lines MiaPaCa-2, PANC1 and BON, and the breast cancer cell line MCF-7 with mTOR inhibitors resulted in an increase in 4E-BP3 protein levels (Fig. 1a). Here, MTOR is linked to breast carcinoma.